Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2025-12-29 @ 12:11 AM
Study NCT ID:
NCT01332968
Status:
COMPLETED
Last Update Posted:
2022-08-11
First Post:
2011-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-08
First Submit QC Date:
None
Study First Post Date:
2011-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-03
Results First Submit QC Date:
None
Results First Post Date:
2017-06-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-09
Last Update Post Date:
2022-08-11
Last Update Post Date Type:
ACTUAL